Results 131 to 140 of about 509,004 (307)
Bee pollen as functional food and environmental bioindicator: current evidence and future challenges
Abstract Bee pollen (BP), a plant‐derived product collected by honey bees, is increasingly promoted as a functional food due to its content of proteins, essential amino acids, lipids, vitamins, minerals, and bioactive compounds such as polyphenols and flavonoids.
Luigi Parrotta, Stefano Del Duca
wiley +1 more source
Respiratory allergy and asthma associated with pesticide exposure amongst women in rural Western Cape [PDF]
Includes bibliographical references.Pesticide exposure has been increasingly associated with adverse respiratory health effects including asthma and allergy. However, few studies have been conducted among women and workers in developing countries.
Ndlovu, Vuyelwa
core +1 more source
Abstract BACKGROUND Alphitobius diaperinus, the lesser mealworm, is an edible insect considered safe for human consumption; however, its proteins show documented cross‐reactivity with crustacean and house dust mite (HDM) allergens, raising potential concerns for allergic populations.
Michelle M Epstein +8 more
wiley +1 more source
ABSTRACT Artificial Intelligence is rapidly transforming allergology by enhancing diagnosis, risk prediction, automation, patient communication, education, and therapy development. Machine learning approaches, including convolutional neural networks, recurrent architectures, and transformer‐based models, enable analysis of complex datasets from ...
Sebastian Seurig +2 more
wiley +1 more source
DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau +11 more
wiley +1 more source
Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma
Jared Silver,1 Andrea Steffens,2 Benjamin Chastek,2 Arijita Deb3 1Medical Affairs, GSK, Durham, NC, USA; 2Optum, Eden Prairie, MN, USA; 3Value, Evidence and Outcomes, GSK, Upper Providence, PA, USACorrespondence: Arijita Deb, Value, Evidence and Outcomes,
Silver J, Steffens A, Chastek B, Deb A
doaj
ABSTRACT The PaCeCAD (Patient Centricity Care in Atopic Dermatitis) Sessions were held on Friday, October 24th, 2025, in Melbourne, Australia, as a conference‐format meeting during the first morning of the 15th Georg Rajka International Symposium on Atopic Dermatitis organized by the International Society of Atopic Dermatitis (ISAD).
Jean‐François Stalder +17 more
wiley +1 more source
ABSTRACT Emollients and cleansers are essential components in managing atopic dermatitis (AD). While international evidence‐based guidelines recommend using gentle cleansers and emollients daily as a foundational therapy for AD, implementation in practice remains suboptimal.
Mette Deleuran +12 more
wiley +1 more source
Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense +4 more
wiley +1 more source

